Isolation and Characterization of Androgen Receptor Mutant, AR(M749L), with Hypersensitivity to 17-Β Estradiol Treatment

Tin Htwe Thin,Liang Wang,Eungseok Kim,Loretta L. Collins,Ravi Basavappa,Chawnshang Chang

DOI: https://doi.org/10.1074/jbc.m206172200

2003-01-01

Abstract:Estrogens, primarily 17␤-estradiol (E 2 ), may play important roles in male physiology via the androgen receptor (AR).It has already been shown that E 2 modulates AR function in LNCaP prostate cancer cells and xenograft CWR22 prostate cancer tissues.Using a molecular model of E 2 bound-AR-ligand binding domain (LBD) and employing site-directed mutagenesis strategies, we screened several AR mutants that were mutated at E 2 -AR contact sites.We found a mutation at amino acid 749, AR(M749L), which confers AR hypersensitivity to E 2 .The reporter assays demonstrate that E 2 can function, like androgen, to induce AR(M749L) transactivation.This E 2 -induced AR mutant transactivation is a direct effect of the AR(M749L), because the transactivation was blocked by antiandrogens.The hypersensitivity of AR(M749L) to E 2 is not due to increased affinity of AR(M749L) for E 2 , rather it may be due to the existence of the proper conformation necessary to maintain E 2 binding to the AR-LBD long enough to result in E 2 -induced transactivation.AR(M749L) transactivation can be further enhanced in the presence of AR coregulators, such as ARA70 and SRC-1.Therefore, amino acid 749 may represent an important site within the AR-LBD that is involved in interaction with E 2 that, when mutated, allows E 2 induction of AR transactivation.